Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.2.64NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.8 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.7 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.41NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.90 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.23NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.30NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1.1.12NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.87NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.33NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.46NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.58 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.26NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.15NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.21NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.31NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CP.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBGNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.98 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.32NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1.1.13NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDTNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.21NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.2.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.617.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.109 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.4.2.2 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.4.2.3 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.4.8 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.617.1 (Kappa)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.4.3 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GS.7.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XWNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1.10NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KG.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDJNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.3.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GK.1.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.5.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.36.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.86.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LV.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.23NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GE.1.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.2.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JC.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KE.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FY.8.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used